This Personalized Crispr Therapy Is Designed to Attack Tumors
In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.
A phase 1 study showed robust responses in patients with TTR amyloidosis with cardiomyopathy, similar to those reported last year in amyloid polyneuropathy.
A CRIPR gene therapy volunteer recently died. His death is now raising questions. Is gene-editing really safe?
The US government is funding tech to determine whether genetic alterations in a virus or pest are an evolutionary quirk—or a lab-engineered danger.
A Qualitative Research Study accomplished by Data Bridge Market research's database, titled “Plant Breeding and CRISPR Plant Market” with 100+ market data